Indo Us Bio-Tech Limited (BOM:541304)
India
· Delayed Price · Currency is INR 156.55
+4.15 (2.72%)
At close: Jul 4, 2025
Indo Us Bio-Tech Revenue
In the fiscal year ending March 31, 2025, Indo Us Bio-Tech had annual revenue of 1.04B INR with 42.56% growth. Indo Us Bio-Tech had revenue of 333.85M in the quarter ending March 31, 2025, with 111.75% growth.
Revenue
1.04B
Revenue Growth
+42.56%
P/S Ratio
3.02
Revenue / Employee
n/a
Employees
883
Market Cap
3.14B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.04B | 310.02M | 42.56% |
| Mar 31, 2024 | 728.36M | 110.92M | 17.96% |
| Mar 31, 2023 | 617.45M | 116.86M | 23.34% |
| Mar 31, 2022 | 500.59M | 99.48M | 24.80% |
| Mar 31, 2021 | 401.10M | 3.49M | 0.88% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,553.24B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Life Insurance Corporation of India | 8,901.58B |
Indo Us Bio-Tech News
- 10 months ago - Indo US Bio-Tech share price surges 3% after signing MoU for Pratap Hybrid Maize -6 - Business Upturn